John Saad, MD
Otolaryngology · la Jolla, CANPI 1710942198
Payments from drug & device makers
What this record shows
This record is dominated by other: $4,182 of the $4,871 with a category attached, or 85.9%. Integra Lifesciences Corporation accounts for 87.1% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $4,338, more than ten times the $142 reported in 2019.
Across 37 payments — averaging $131.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$4K
- Optinose US, Inc.$222
- GSK$116
- Ambu Inc.$49
- Stryker$36
- Kerecis Limited$28
- plus $177 from 9 others
What the payments were for
- Food & beverage$68814%
- Other$4,18286%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 8 | $4,242 |
| Optinose US, Inc. | 12 | $222 |
| GSK | 4 | $116 |
| Ambu Inc. | 2 | $49 |
| Stryker | 1 | $36 |
| Kerecis Limited | 1 | $28 |
| Hospira, Inc. | 1 | $27 |
| Aroa Biosurgery Incorporated | 1 | $26 |
| Neurent Medical Limited | 1 | $25 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Baxter Healthcare | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Olympus America Inc. | 1 | $14 |
| Misonix Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMNIOEXCEL PLUS$3,130
- AMNIOEXCEL$1,052
How this compares
$4,871 in reported general payments places this provider in the 80th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 303 | $6,024 |
| Azelastine Hcl | 77 | $1,918 |
| Ipratropium Bromide | 12 | $454 |
| Potassium Chloride | 14 | $252 |
| Doxycycline Hyclate | 24 | $138 |
| Hydrochlorothiazide | 19 | $124 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $83 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 11 | $61 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $47 |
| Cephalexin | 14 | $45 |
| Prednisone | 15 | $26 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in la Jolla
- Christopher Bergeronla Jolla$63K
- Brian WeeksSan Diego$924K
- Randall OwRoseville$613K
- Amir MoradiVista$389K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
- Todd MillerNewport Beach$259K
- Jeffrey SuhLos Angeles$223K
- Dennis TangLos Angeles$209K
- Jeffrey FeinfieldThousand Oaks$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.